Evidence map›Paper›PMID 26959336›Full record

ReviewNeuroscience and biobehavioral reviews2016

Assessing anhedonia in depression: Potentials and pitfalls.

Sakina J Rizvi, Diego A Pizzagalli, Beth A Sproule, Sidney H Kennedy

Registry-linked trialAbstract readReview
In one paragraph

Review in Neuroscience and biobehavioral reviews, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05487885 (Anhedonia, Development, and Emotions), which is not on this map. Cited by 259 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
259citing papers in PubMed, 4 pooled it
38.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05487885 phase4completednot on this mapstarted 2022, after this paper: background citation

Anhedonia, Development, and Emotions: Phenotyping and Therapeutics (ADEPT) Study

TypeinterventionalSponsorErika ForbesRan2022 to 2025Enrolled123ConditionsDepression, AnhedoniaArmsContinuous theta burst stimulation (cTBS), Positive Affect Training, Ketamine Injectable Solution
3 · Its place in the literature

Who cites it

259 citing papers in PubMed, 4 syntheses or guidelines pooled it, 565 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Computationally Informed Insights Into Anhedonia and Treatment by Kappa Opioid Receptor Antagonism.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2025
    Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Article
  15. Article
  16. Article
  17. Article
  18. Dopaminergic modulation of social reward anticipation in depression: neural effects of amisulpride versus placebo.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  19. Article
  20. On the relationships between apathy, depression and anhedonia.Journal of neurology, neurosurgery, and psychiatry · 2026
    Article

199 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Sakina J RizviASR Chair in Suicide and Depression Studies Program, Department of Psychiatry, St. Michael's Hospital, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. Electronic address: rizvisa@smh.ca.
Diego A PizzagalliDepartment of Psychiatry, Harvard Medical School and McLean Hospital, Belmont, MA, USA.
Beth A SprouleDepartment of Clinical Pharmacy, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Pharmaceutical Sciences, University of Toronto, Toronto, Ontario, Canada.
Sidney H KennedyASR Chair in Suicide and Depression Studies Program, Department of Psychiatry, St. Michael's Hospital, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada.
University of Toronto · CAHarvard University · USSt. Michael's Hospital · CA

Funding

Early Life Stress and Depression: Molecular and Functional Imaging ApproachesR01MH095809 · NIMH · MCLEAN HOSPITAL · PI DU, FEI, PIZZAGALLI, DIEGO A · 2012 to 2024
$6.4M
Neuroimaging Studies of Reward Processing in DepressionR01MH068376 · NIMH · MCLEAN HOSPITAL · PI PIZZAGALLI, DIEGO A · 2004 to 2014
$4.5M
Multi level Analysis of Positive Valence Systems Across Mood DisordersR01MH101521 · NIMH · MCLEAN HOSPITAL · PI PIZZAGALLI, DIEGO A · 2013 to 2016
$2.1M
NIMH NIH HHS R01 MH068376NIMH NIH HHS R01 MH095809NIMH NIH HHS R01 MH101521
6 · The paper itself

Abstract

The resurgence of interest in anhedonia within major depression has been fuelled by clinical trials demonstrating its utility in predicting antidepressant response as well as recent conceptualizations focused on the role and manifestation of anhedonia in depression. Historically, anhedonia has been understood as a "loss of pleasure", yet neuropsychological and neurobiological studies reveal a multifaceted reconceptualization that emphasizes different facets of hedonic function, including desire, effort/motivation, anticipation and consummatory pleasure. To ensure generalizability across studies, evaluation of the available subjective and objective methods to assess anhedonia is necessary. The majority of research regarding anhedonia and its neurobiological underpinnings comes from preclinical research, which uses primary reward (e.g. food) to probe hedonic responding. In contrast, behavioural studies in humans primarily use secondary reward (e.g. money) to measure many aspects of reward responding, including delay discounting, response bias, prediction error, probabilistic reversal learning, effort, anticipation and consummatory pleasure. The development of subjective scales to measure anhedonia has also increased in the last decade. This review will assess the current methodology to measure anhedonia, with a focus on scales and behavioural tasks in humans. Limitations of current work and recommendations for future studies are discussed.

Indexed as

AnhedoniaDepressionHumansMotivationRewardAnhedoniaAnticipationDelay discountingEffortGamblingMajor depressionMonetary incentive delayPrediction errorResponse biasRewardScale

Identifiers

PMID26959336
PMCPMC4856554
OpenAlexW2293194104

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.